Literature DB >> 9808581

Are complicated forms of celiac disease cryptic T-cell lymphomas?

F Carbonnel1, L Grollet-Bioul, J C Brouet, M F Teilhac, J Cosnes, R Angonin, M Deschaseaux, F P Châtelet, J P Gendre, F Sigaux.   

Abstract

We assessed the clonality of duodenal mucosal T cells in patients with celiac disease and controls. Fifteen adult patients were studied. Four patients had a complicated celiac disease, 3 did not respond to a gluten-free diet, and 2 had an ulcerative jejunitis (including 1 patient with nonresponsive celiac disease). Seven patients had an untreated celiac disease responsive to a gluten-free diet. Histological examination of duodenal biopsies of these 11 patients showed benign-appearing celiac disease without evidence of lymphoma. Four patients with nonulcer dyspepsia and normal duodenal biopsies served as controls. TCRgamma gene rearrangements were analyzed by multiplex polymerase chain reaction on DNA extracted from duodenal biopsies. Major clonal rearrangements of the T-cell receptor were found in 4 cases, all with complicated celiac disease. Monoclonality was confirmed by DNA sequencing of the junctional region in 3 cases and by hybridization with clone-specific oligoprobes. Patients with celiac disease responsive to gluten-free diet had mainly a polyclonal pattern, with 1 of them having an oligoclonal rearrangement. An oligoclonal pattern was also observed in 2 control patients. Three patients with complicated celiac disease evolved to T-cell lymphoma with liver (n = 2) or bone marrow (n = 1) invasion. Identical clones were found in the enteropathic duodenojejunum and peripheral blood in the patient with large-cell lymphoma with bone marrow invasion. This study suggests that complicated celiac disease is a cryptic T-cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9808581

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  First steps in unraveling the genotype of enteropathy-type T-cell lymphoma.

Authors:  Ming-Qing Du; Peter G Isaacson
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

2.  Gastrointestinal intraepithelial lymphocytes and T cell lymphomas.

Authors:  I N Farstad; K E A Lundin
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

Review 3.  Refractory sprue.

Authors:  Andrea N Culliford; Peter H R Green
Journal:  Curr Gastroenterol Rep       Date:  2003-10

4.  From hyperplasia to T cell lymphoma.

Authors:  N Cerf-Bensussan; N Brousse; C Cellier
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

5.  Inflammatory bowel disease mimicking alimentary lymphosarcoma in a cat.

Authors:  L Ragaini; G Aste; L Cavicchioli; A Boari
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

Review 6.  An approach to duodenal biopsies.

Authors:  S Serra; P A Jani
Journal:  J Clin Pathol       Date:  2006-05-05       Impact factor: 3.411

7.  Successful treatment of enteropathy-associated T cell lymphoma with autologous stem cell transplant.

Authors:  Catherine Rongey; Ivana Micallef; Thomas Smyrk; Joseph Murray
Journal:  Dig Dis Sci       Date:  2006-06       Impact factor: 3.199

8.  Intestinal B cell lymphoma associated with chronic hepatitis C and celiac disease.

Authors:  Sahin Coban; Murat Palabiyikoğlu; Arzu Ensari; Ramazan Idilman; Seyfettin Köklü; Omer Faruk Yolcu; Necati Ormeci
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

9.  Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.

Authors:  A Al-Toma; W H M Verbeek; M Hadithi; B M E von Blomberg; C J J Mulder
Journal:  Gut       Date:  2007-04-30       Impact factor: 23.059

10.  Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expression.

Authors:  I N Farstad; F-E Johansen; L Vlatkovic; J Jahnsen; H Scott; O Fausa; A Bjørneklett; P Brandtzaeg; T S Halstensen
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.